Equities
Health CareHealth Care Equipment & Services
  • Price (USD)394.43
  • Today's Change-0.84 / -0.21%
  • Shares traded415.85k
  • 1 Year change51.28%
  • Beta0.8964
Data delayed at least 15 minutes, as of May 22 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, including dental, vision, and other supplemental health and financial protection products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

  • Revenue in USD (TTM)67.72bn
  • Net income in USD2.61bn
  • Incorporated1964
  • Employees46.00k
  • Location
    Humana Inc500 W Main StLOUISVILLE 40202United StatesUSA
  • Phone+1 (502) 580-1000
  • Fax+1 (302) 636-5454
  • Websitehttp://www.humana.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HUM:NYQ since
announced
Transaction
value
Enclara Health IncAnnounced16 Dec 201916 Dec 2019Announced11.70%--
Data delayed at least 15 minutes, as of May 22 2020 21:00 BST.

Institutional shareholders

45.20%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20209.86m7.46%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20209.51m7.20%
Capital Research & Management Co. (International Investors)as of 31 Mar 20208.35m6.32%
BlackRock Fund Advisorsas of 31 Mar 20206.44m4.87%
SSgA Funds Management, Inc.as of 31 Mar 20205.82m4.40%
Fidelity Management & Research Co. LLCas of 31 Mar 20205.50m4.16%
Capital Research & Management Co. (World Investors)as of 31 Mar 20204.81m3.64%
Capital Research & Management Co. (Global Investors)as of 31 Mar 20203.70m2.80%
Renaissance Technologies LLCas of 31 Mar 20203.53m2.67%
Wellington Management Co. LLPas of 31 Mar 20202.22m1.68%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.